Evercore ISI reiterates Karman stock rating after filing delay

Karman filed for a short 10-K reporting delay but expects to file within the standard 15-day extension; Evercore ISI reiterated Outperform with a $125 target while the stock trades at $86.15 and is up 139% over the past year. Q4 revenue topped expectations, EBITDA and adjusted EPS met forecasts, with 31% organic growth and a 31% EBITDA margin; management raised fiscal 2026 outlook despite some award timing delays. Multiple brokers (Piper Sandler $127 PT, KeyBanc, William Blair, Truist) remain positive, while BWS Financial is the notable dissent citing cash flow and rising unbilled revenue. Evercore frames the delay as procedural rather than indicative of material financial issues.

Analysis

The immediate implication is idiosyncratic event risk compressing implied volatility and creating a window where information asymmetry is large but transient. Expect pricing to be driven more by perceived accounting/audit tail risk and working-capital dynamics than by base-case revenue growth over the next 3–6 months; that creates a premium for downside protection but also an opportunity to buy forward optional convexity cheaply once the filing window closes cleanly.

On the operational side, accelerated backlog plus recent acquisitions shifts the cash-conversion profile: unbilled receivables rising faster than cash receipts will compress free cash flow and could force short-term financing or defer shareholder returns. If integration synergies prove slower, margin compression can persist for 2–4 quarters even as revenue comp grows, creating a stretch between EBITDA optics and cash generation that credit-sensitive investors will punish first.

Second-order supplier dynamics matter: higher build rates in missiles/drones push demand into niche sub-tier suppliers (avionics, propulsion, guidance), tightening lead times and input costs which can bite margins or accelerate capex needs for the company and its suppliers. This bifurcates winners—companies that can pass thru pricing or scale capacity—and losers—small suppliers with constrained balance sheets—creating actionable relative-value opportunities across the supply chain over the next 6–18 months.

Key Decisions for Investors

• KRMN long with defined downside (ticker: KRMN) — Buy shares and hedge with a 6-month 15% OTM put (ratio sized to cap maximum drawdown at ~10–12% net cost). Rationale: market likely underprices clearing of audit/filing noise; reward if filing is clean and backlog converts is asymmetric (40–80% upside potential over 6–12 months) while downside is limited to the put strike premium.
• KRMN time-spread call structure (ticker: KRMN) — Buy a 12-month LEAP call ~25% OTM and finance by selling multiple 2–3 month 15% OTM calls (roll premium). Rationale: captures multi-quarter margin recovery and backlog conversion while monetizing near-term elevated implied vol; scenario payoff >2x if integration shows traction within 6–12 months, loss limited to net premium if near-term noise persists.
• Idiosyncratic long/sector hedge (tickers: KRMN long / XAR short) — Pair equal-dollar long KRMN vs short XAR for 6–9 months to isolate company-specific upside vs sector moves. Rationale: neutralizes broad defense beta and isolates payoff from execution on backlog and integration; risk if sector re-rates higher broadly.
• Event volatility hedge around next filing window (ticker: KRMN options) — Buy a 30–60 day put/call strangle sized modestly (~2–4% of portfolio) centered on the expected filing event. Rationale: cheap tail insurance to monetize any knee-jerk move from filing outcomes; cost is limited to premium, payoff is large if filing contains surprises.